Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Walter Reed Army Medical Center |
---|---|
Information provided by: | Walter Reed Army Medical Center |
ClinicalTrials.gov Identifier: | NCT00414011 |
The purpose of this study is a prospective,double-blinded, randomized trial to compare the rate of healing following PRK after the use of two commercially available 4th generation fluoroquinolones, moxifloxacin and gatifloxacin.
Condition | Intervention |
---|---|
Epithelium, Corneal |
Drug: Moxifloxacin Drug: Gatifloxacin |
Study Type: | Interventional |
Study Design: | Randomized, Double-Blind, Uncontrolled, Parallel Assignment |
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, District of Columbia | |
Walter Reed Army Medical Center | |
Washington, District of Columbia, United States, 20307 |
Principal Investigator: | KRAIG S. BOWER, MD | Walter Reed Army Medical Center |
Study ID Numbers: | WRAMC WU # 04-2335-99e |
Study First Received: | December 19, 2006 |
Last Updated: | December 19, 2006 |
ClinicalTrials.gov Identifier: | NCT00414011 |
Health Authority: | United States: Federal Government |
Removal of corneal epithelium followed by excimer laser treatment during prk |
Fluoroquinolones Moxifloxacin Gatifloxacin |
Anti-Infective Agents Therapeutic Uses Pharmacologic Actions |